Published in FASEB J on December 08, 2000
Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J (2003) 2.06
The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J (2008) 1.73
Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal (2009) 1.62
Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest (2003) 1.58
Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. J Biol Chem (2010) 1.19
Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J (2004) 0.98
Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Invest (2004) 0.98
Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosis. Biochem J (2001) 0.93
FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels. PLoS One (2014) 0.81
Production of multiple brain-like ganglioside species is dispensable for fas-induced apoptosis of lymphoid cells. PLoS One (2011) 0.79
Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells. Glycobiology (2009) 0.78
Impaired odour discrimination on desynchronization of odour-encoding neural assemblies. Nature (1997) 4.15
Dynamic optimization of odor representations by slow temporal patterning of mitral cell activity. Science (2001) 3.32
Complexity and the nervous system. Science (1999) 3.26
Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol (1999) 2.87
Odour encoding by temporal sequences of firing in oscillating neural assemblies. Nature (1996) 2.86
A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J (1997) 2.56
Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol (1998) 2.54
Odor- and context-dependent modulation of mitral cell activity in behaving rats. Nat Neurosci (1999) 2.28
[4 cases of trisomy for the short arm of chromosome 9. Individualization of a new morbid entity]. Ann Genet (1970) 2.23
Encoding of olfactory information with oscillating neural assemblies. Science (1994) 2.15
Distinct mechanisms for synchronization and temporal patterning of odor-encoding neural assemblies. Science (1996) 2.10
Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04
Model of transient oscillatory synchronization in the locust antennal lobe. Neuron (2001) 1.99
Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol (2007) 1.90
DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature (1980) 1.86
Short-term memory in olfactory network dynamics. Nature (1999) 1.86
Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem (1997) 1.84
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia (2004) 1.81
Computation of object approach by a wide-field, motion-sensitive neuron. J Neurosci (1999) 1.77
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
Model of cellular and network mechanisms for odor-evoked temporal patterning in the locust antennal lobe. Neuron (2001) 1.71
Who reads temporal information contained across synchronized and oscillatory spike trains? Nature (1998) 1.70
Mechanisms of bleomycin-induced lung damage. Arch Toxicol (1991) 1.69
N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry (1998) 1.68
Survival as an index of adequacy of dialysis. Kidney Int (1992) 1.66
Disruption of GABA(A) receptors on GABAergic interneurons leads to increased oscillatory power in the olfactory bulb network. J Neurophysiol (2001) 1.62
Signalling sphingomyelinases: which, where, how and why? Biochim Biophys Acta (1999) 1.60
Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet (1995) 1.59
Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia (2006) 1.58
Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol (1982) 1.58
Dynamical encoding by networks of competing neuron groups: winnerless competition. Phys Rev Lett (2001) 1.58
Fibrinogen. Int J Biochem Cell Biol (1999) 1.57
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS. Neurology (2002) 1.56
Elementary computation of object approach by wide-field visual neuron. Science (1995) 1.56
Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem (1998) 1.52
Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant (1995) 1.51
[Trisomy for the distal part of the short arm of the number 3 chromosome in 3 siblings. First example of chromosomal insertion: INS(7;3)(q 31;p 21 p 26)]. Ann Genet (1972) 1.50
Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol (1998) 1.49
The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant (1999) 1.49
Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J Neurochem (2001) 1.47
Immunoperoxidase staining of surface and intracellular immunoglobulin in human neoplastic lymphoid cells. J Clin Pathol (1980) 1.45
How to keep the dialysis patients normotensive? What is the secret of Tassin? Nephrol Dial Transplant (1997) 1.40
GABAergic synapses in the antennal lobe and mushroom body of the locust olfactory system. J Comp Neurol (1996) 1.35
Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob Agents Chemother (1983) 1.34
Clinical assessment of dry weight. Nephrol Dial Transplant (1996) 1.34
[Mosaic 14 trisomy in a female child with multiple abnormalities]. Ann Genet (1975) 1.34
Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J (1996) 1.31
The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax (1998) 1.29
Sphingosine-1-phosphate in cell growth and cell death. Ann N Y Acad Sci (1998) 1.29
Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic Biol Med (2001) 1.28
Signaling pathways activated by daunorubicin. Blood (2001) 1.28
Sphingolipid mediators in cardiovascular cell biology and pathology. Circ Res (2001) 1.26
Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol (1999) 1.25
Endoscopic ultrasonographic signs of portal hypertension in cirrhosis. Gastrointest Endosc (1996) 1.25
Invariance of angular threshold computation in a wide-field looming-sensitive neuron. J Neurosci (2001) 1.24
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia (2006) 1.24
Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer (2005) 1.24
Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant (2010) 1.23
Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol Sci (2000) 1.22
Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol Appl Pharmacol (1986) 1.21
Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J Pharmacol Exp Ther (1990) 1.18
In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction. Cancer Res (1992) 1.17
Sphingomyelinases and Niemann-Pick disease. J Clin Chem Clin Biochem (1986) 1.16
Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Cancer Res (1994) 1.16
Relationship between afferent and central temporal patterns in the locust olfactory system. J Neurosci (1999) 1.16
[Partial 7q trisomy due to t(7;12) (q22;q24) familial translocation]. Ann Genet (1972) 1.15
Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol (2001) 1.14
Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J Biol Chem (1999) 1.13
Influence of stress on extracellular matrix and integrin biology. Oncogene (2011) 1.13
Suites of plant traits in species from different stages of a Mediterranean secondary succession. Plant Biol (Stuttg) (2010) 1.12
Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ (2001) 1.12
Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol (1996) 1.10
Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells. Leukemia (2013) 1.10
Acute myocardial infarction related to myocardial bridging. Eur Heart J (1995) 1.10
Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant (1999) 1.09
A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J (2001) 1.09
Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res (2000) 1.09
Continuing improvements in valvular bioprostheses. J Thorac Cardiovasc Surg (1982) 1.09
Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood (2001) 1.09
Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J (2000) 1.08
Involvement of FAN in TNF-induced apoptosis. J Clin Invest (2001) 1.08
Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. Leukemia (2008) 1.07